Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Chengdu Kanghua Biological Products Co., Ltd.
Sector
Healthcare
Industry
Biotechnology
Employees
620
First IPO Date
June 16, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Fu Wang | Vice President | 0 | 1969 |
| Hongbo Wu | President & Non-Independent Director | 0 | 1968 |
| Huaigong Chen | Vice President & Quality Manager | 0 | 1972 |
| Wennian Wu | Vice President, Chief Financial Officer, Secretary of the Board & Director | 0 | 1983 |
| Ping Liu | Accounting Supervisor | 0 | N/A |
AD
Description
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.
AD
